Eliminating Cervical Cancer Conference 2026
Join us at the Eliminating Cervical Cancer 2026 Conference (ECC2026) taking place 25–27 November at the Sofitel Melbourne and online (with a cocktail reception to kick off proceedings on the 24th). Centred on the theme “Recognising Progress. Addressing Challenges”, this milestone event marks the tenth conference of its kind hosted by C4. ECC2026 brings together leading experts in vaccination, screening and treatment, offering panel discussions, expert insights and networking opportunities—all focused on accelerating progress toward the elimination of cervical cancer.
Register by 31st October to save
Register by 31st October 2026 to secure the standard registration rate. From 1st November 2026, the late registration rate of $1,599.50 (+GST) will apply. Complete your registration before then to take advantage of the lower standard rate.
Registration details
- Standard rate: $1,545
- Virtual attendance (standard): $400
- Virtual attendance (LMIC resident): Free
All rates are excusive of GST.
Program
Wednesday 25th November
Day 1 – HPV Vaccination
8:15-9:00 Welcome & opening address
Welcome & housekeeping
Prof. Karen Canfell AC
Welcome to Country
Opening address
Mr Chris Cannon
9:00-10:30 Domestic session – Pillar 1
Chair: Prof. Julia Brotherton
Improving HPV vaccination rates for Aboriginal Young people through a social media campaign
Dr Natalie Strobel
HPV vaccination coverage for Australians with disability: integrated data challenges and findings
Prof. Claire Vajdic & Ms Sarah Walmsley
10:30-11:00 Morning tea
11:00-12:30 Scientific session – Pillar 1
Chair: Prof. Kristine Macartney
Scientific Plenary: HPV Vaccination in a Changing World: Sustaining Momentum to 2030
Ms Emily Kobayashi
Health impacts, cost-effectiveness and budget estimates to support the introduction of HPV vaccine into the national immunization program in Vietnam
Dr Diep Nguyen
Impact of HPV vaccination on rates of cervical precancer treatment and preterm births in women giving birth in NSW, Australia, 2000-2020
Dr Susan Yuill
Socioeconomic disparities in HPV vaccination coverage using the Person Level Integrated Data Asset
Ms Samrawit Fetene
12:30-1:30 Lunch
1:30-3:30 International session – Pillar 1
Chair: Prof. Kristine Macartney
PNG progress to National vaccination
Dr Edward Waramin
Vietnam: Introduction plan and evaluation of HPV role out
A/Prof Nguyen Van Trang
Solomon Islands: The Big HPV vaccination Catch-up campaign and what happens after
Ms Jennifer Anga
3:30-4:00 Afternoon tea
4:00-5:00 Cross-pillar topic: Elimination Planning; Indonesia a case study
Chair: Prof. Karen Canfell
EPICC and elimination planning for sustainability
Prof. Karen Canfell
District situation analysis tool
A/Prof Claire Nightingale
Thursday 26th November
Day 2 – Screening and pre-cancer treatment
8:30-10:00 Domestic session – Pillar 2
Co-chairs: A/Prof. Megan Smith & A/Prof. Lisa Whop
C4 report: Update on Screening coverage and equity
A/Prof. Megan Smith & A/Prof. Lisa Whop
Optimising Cervical Screening with and for People with Intellectual Disability (Screen Equal)
Prof. Deborah Bateson & Ms Sarah Simmonds
Screen Your Way
Dr Louise Mitchell
Supporting Choice
Dr Tessa Saunders
Rethinking how we deliver HPV vaccination with Aboriginal and Torres Strait Islander Young People’
Dr Natalie Strobel
10:00-10:30 Morning tea
10:30-12:30 Scientific session – Pillar 2
Chair: Prof. Marion Saville
Scientific Plenary: Compass and Focal side by side
Dr. Gina Ogilvie and Prof. Karen Canfell
Implementation of self-collected cervical screening in an under-screened, culturally and linguistically diverse antenatal population: a quality improvement study
Dr Mandy Wang
Reaching women for cervical screening through antenatal care in hospitals: assessing implementation and impact of ‘Screening During Pregnancy’ across New South Wales
Ms Alison Jones
Expanding Access to Cervical Screening: Outcomes and Consumer Acceptability of a Telehealth Self-Collection CST Model in South Australia
Ms Kelly Stegmeyer
A Small Island, A Big Step: Launching the Niue Cervical Screening Programme
Dr Ebony Pulu
Exploring Indonesian midwives’ training experiences and knowledge related to cervical screening and HPV DNA testing in East Nusa Tenggara province
Ms Sandra Frans
What is the optimal screening strategy to achieve cervical cancer elimination in Ethiopia: Implications for national strategy
Dr Muluken Gizaw
Timely initiation of cervical screening at age 25 in Australia: findings from Australia’s national cervical screening program
Dr Monjura Nisha
It Starts With Me, supporting Aboriginal health workforce to become Certified Cervical Screening Providers
Ms Debbie Mars
12:30-1:30 Lunch
1:30-3:30 International session – Pillar 2
Co-chairs: Vanessa Price & Dr. Claire Nightingale
EPICC Update: Overview coverage and follow-up
Dr Telma Costa
Case study achievements and challenges: Timor
Dr Merita Monteiro
Role of centralised testing: Malaysia
Dr Su Pei Khoo
Case study achievements and challenges: Indonesia
Dr Andyta Nalaresi
Case study achievements and challenges : Fiji
Dr Rachel Devi
Case study achievements and challenges: PNG
Dr Paulus Ripa
3:30-4:00 Afternoon tea
4:00-5:00 Cross-pillar session: : Case study the search for high quality affordable HPV tests
Chair: Prof. Marion Saville
Brief intro: Global estimates of HPV test demand
A/Prof. Kate Simms
Test slection: TPP and the role of validation
A/Prof. Dave Hawkes
Update on clinically validated HPV tests
Dr Marc Arbyn
WHO extended genotyping guidelines
A/Prof. Kate Simms
6:30-11:00 Conference Dinner
Friday 27th November
Day 3 – Treatment
9:00-10:30 Domestic session – Pillar 3
Chair: A/Prof. Orla MacNally
C4 report: Update on treatment coverage and equity
Dr Susan Yuill
Treatment Guidelines
Dr Dana Stefanovic
Access to care: Consumer voice
Ashlee William Barnes
Key note address
Hon Rebecca White MP
10:30-11:00 Morning tea
11:00-12:30 Scientific session – Pillar 3
Chair: Prof. Karen Canfell
Scientific Plenary: Building global treatment capacity and linkages to care
Dr Kathleen Schmeler
A collaborative equilibrium approach to co-design of cervical cancer patient education in resource-poor settings: A case study from Indonesia
Prof. Linda Bennett
Global Cervical Cancer Elimination and Control Policy Analysis
Ms Amelia Hyatt
Immunotherapy for locally advanced cervical cancer: a systematic review to inform the first Australian Cervical Cancer Management Guidelines
Dr Susan Yuill
Role of fluorodeoxyglucose positron emission tomography/computed tomography in addition to standard staging in early-stage cervical cancer: a systematic review identifying an evidence gap
Dr Dana Stefanovic
12:30-1:30 Lunch
1:30-3:30 International session – Pillar 3
Co-chairs: Dr Ai Ling Tan & Dr Telma Costa
Estimates of global surgical demand
Tay Za Kyi Win
IGCS program pre-invasive
Dr Ai Ling Tan
IGCS program invasive
Dr Nanise Sikiti & Dr Una Tabua
Cervical Cancer-associated Suffering and the Palliative Care Imperative
Dr Eric Krakauer M.D.
Role of CSOs
Max Albert
3:30 – 3:45 Closing
3:45 – 4:15 Afternoon tea
Note that the program is subject to change by the organising committee
Conference Co-Chairs
Professor Marion Saville AM
Professor Karen Canfell AC
Session Chairs
Please check back as further session chairs are confirmed over the coming months.
Professor Julia Brotherton
Vanessa Price
A/Prof. Megan Smith
A/Prof. Lisa Whop
And: Prof. Kristine Macartney, Dr Claire Nightingale, Prof. Andrew Vallely, A/Prof. Orla MacNally, Dr Ai Ling Tan, Dr Telma Costa
Speakers
Please check back as further speakers are confirmed over the coming months.
Max Albert
Jenniffer C. Anga
Professor Deborah Bateson AM
Dr Su Pei Khoo
Emily Kobayashi
Eric L. Krakauer, MD, PhD
Dr Louise Mitchell
Dr Andyta Nalaresi Hartono
Dr Gina Ogilvie
Dr Paulus Ripa
Dr Tessa Saunders
Sarah Simmonds
A/Prof. Kate Simms
A/Prof. Megan Smith
Dana Stefanovic
A/Prof Natalie Strobel
Prof. Claire Vajdic
Sarah Walmsley
A/Prof. Lisa Whop
And: Dr Telma Costa, Dr Kathleen Schmeler
ECC2026 Partners
Premium Partner
Dinner Partner
Espresso Partner
ECC2026 Exhibitors
